DAPK3 and neoplasm: In this study, we demonstrated the ability of systems biology network to identify some key apoptotic kinase targets, such as AMPK and ZIPK in cervical cancer, and thus provided a small molecule activator (BL-AD008) as a new potential anti-tumor drug in cervical cancer therapy.